These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 11848504

  • 1. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE.
    Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
    [Abstract] [Full Text] [Related]

  • 2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 3. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 4. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
    Harris RE, Alshafie GA, Abou-Issa H, Seibert K.
    Cancer Res; 2000 Apr 15; 60(8):2101-3. PubMed ID: 10786667
    [Abstract] [Full Text] [Related]

  • 5. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV.
    Cancer Res; 2005 Sep 01; 65(17):8022-7. PubMed ID: 16140976
    [Abstract] [Full Text] [Related]

  • 6. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
    Alshafie GA, Harris RE, Robertson FM, Parrett ML, Ross M, Abou-Issa H.
    Anticancer Res; 1999 Sep 01; 19(4B):3031-6. PubMed ID: 10652588
    [Abstract] [Full Text] [Related]

  • 7. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 8. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats.
    Kubatka P, Kalická K, Chamilová M, Ahlersová E, Ahlers I, Bojková B, Adámeková E.
    Neoplasma; 2002 Feb 01; 49(4):255-9. PubMed ID: 12382025
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib.
    Nishimura N, Urade M, Hashitani S, Noguchi K, Manno Y, Takaoka K, Sakurai K.
    J Oral Pathol Med; 2004 Nov 01; 33(10):614-21. PubMed ID: 15482328
    [Abstract] [Full Text] [Related]

  • 10. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
    Banerjee S, Bueso-Ramos C, Aggarwal BB.
    Cancer Res; 2002 Sep 01; 62(17):4945-54. PubMed ID: 12208745
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
    Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ.
    Cancer Res; 2002 Oct 01; 62(19):5405-7. PubMed ID: 12359744
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
    Alshafie GA, Abou-Issa HM, Seibert K, Harris RE.
    Oncol Rep; 2000 Oct 01; 7(6):1377-81. PubMed ID: 11032948
    [Abstract] [Full Text] [Related]

  • 13. [Chemopreventive effect of tamoxifen combined with celecoxib on DMBA-induced breast cancer in rats].
    Kang HF, Wang XJ, Liu XX, Dai ZJ, Xue FJ, Xue XH.
    Ai Zheng; 2006 Nov 01; 25(11):1346-50. PubMed ID: 17094899
    [Abstract] [Full Text] [Related]

  • 14. [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].
    Kang HF, Wang XJ, Liu XX, Dai ZJ, Xue FJ, Xue XH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 01; 26(11):1599-602. PubMed ID: 17121709
    [Abstract] [Full Text] [Related]

  • 15. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.
    Cancer Res; 2001 May 01; 61(9):3647-52. PubMed ID: 11325834
    [Abstract] [Full Text] [Related]

  • 16. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
    Lanza-Jacoby S, Miller S, Flynn J, Gallatig K, Daskalakis C, Masferrer JL, Zweifel BS, Sembhi H, Russo IH.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 01; 12(12):1486-91. PubMed ID: 14693742
    [Abstract] [Full Text] [Related]

  • 17. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis.
    Koo KL, Tejwani GA, Abou-Issa H.
    Anticancer Res; 1996 Dec 01; 16(4A):1893-8. PubMed ID: 8712718
    [Abstract] [Full Text] [Related]

  • 18. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
    Jang TJ, Jung HG, Jung KH, O MK.
    Int J Exp Pathol; 2002 Aug 01; 83(4):173-82. PubMed ID: 12485462
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ.
    Cancer Res; 2004 Feb 01; 64(3):1181-9. PubMed ID: 14871855
    [Abstract] [Full Text] [Related]

  • 20. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S, Mevissen M, Löscher W.
    Cancer Res; 1999 Aug 01; 59(15):3627-33. PubMed ID: 10446973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.